Treatment of promyelocytic blast crisis of chronic myelogenous leukemia with all trans-retinoic acid

Peter H. Wiernik, Janice P. Dutcher, Elisabeth M. Paietta, Walter N. Hittelman, Rohini Vyas, Margery Strack, Sylvie Castaigne, Laurent Degos, Robert E. Gallagher

Research output: Contribution to journalArticle

35 Citations (Scopus)

Abstract

Two recent reports have described major clinical benefits from all-trans-retinoic acid (tRA) therapy of patients with promyelocytic leukemia (APL). This paper describes the first patient with a blast crisis of chronic myelogenous leukemia (CML-BC) who responded to oral tRA therapy. In vitro marrow studies, including clonogenic assays, immunopheno-typing, cytogenetics and premature chromosome condensation together with chromosome painting provided evidence for the in vivo differentiation and maturation of the malignant cells. The patient achieved a partial remission with reversal of all clinical features of disease, including normalization of peripheral blood counts, complete resolution of fever, fatigue and splenomegaly, and marked maturation of the bone marrow. This response to tRA in CML-BC is unique, and broadens the spectrum of diseases which may respond to retinoids.

Original languageEnglish (US)
Pages (from-to)504-509
Number of pages6
JournalLeukemia
Volume5
Issue number6
StatePublished - Jun 1991

Fingerprint

Blast Crisis
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Tretinoin
Bone Marrow
Chromosome Painting
Blood Cell Count
Splenomegaly
Retinoids
Cytogenetics
Fatigue
Leukemia
Fever
Therapeutics
Chromosomes

ASJC Scopus subject areas

  • Cancer Research
  • Hematology

Cite this

Wiernik, P. H., Dutcher, J. P., Paietta, E. M., Hittelman, W. N., Vyas, R., Strack, M., ... Gallagher, R. E. (1991). Treatment of promyelocytic blast crisis of chronic myelogenous leukemia with all trans-retinoic acid. Leukemia, 5(6), 504-509.

Treatment of promyelocytic blast crisis of chronic myelogenous leukemia with all trans-retinoic acid. / Wiernik, Peter H.; Dutcher, Janice P.; Paietta, Elisabeth M.; Hittelman, Walter N.; Vyas, Rohini; Strack, Margery; Castaigne, Sylvie; Degos, Laurent; Gallagher, Robert E.

In: Leukemia, Vol. 5, No. 6, 06.1991, p. 504-509.

Research output: Contribution to journalArticle

Wiernik, PH, Dutcher, JP, Paietta, EM, Hittelman, WN, Vyas, R, Strack, M, Castaigne, S, Degos, L & Gallagher, RE 1991, 'Treatment of promyelocytic blast crisis of chronic myelogenous leukemia with all trans-retinoic acid', Leukemia, vol. 5, no. 6, pp. 504-509.
Wiernik PH, Dutcher JP, Paietta EM, Hittelman WN, Vyas R, Strack M et al. Treatment of promyelocytic blast crisis of chronic myelogenous leukemia with all trans-retinoic acid. Leukemia. 1991 Jun;5(6):504-509.
Wiernik, Peter H. ; Dutcher, Janice P. ; Paietta, Elisabeth M. ; Hittelman, Walter N. ; Vyas, Rohini ; Strack, Margery ; Castaigne, Sylvie ; Degos, Laurent ; Gallagher, Robert E. / Treatment of promyelocytic blast crisis of chronic myelogenous leukemia with all trans-retinoic acid. In: Leukemia. 1991 ; Vol. 5, No. 6. pp. 504-509.
@article{d26031e224904e328a6fe25f4b82379c,
title = "Treatment of promyelocytic blast crisis of chronic myelogenous leukemia with all trans-retinoic acid",
abstract = "Two recent reports have described major clinical benefits from all-trans-retinoic acid (tRA) therapy of patients with promyelocytic leukemia (APL). This paper describes the first patient with a blast crisis of chronic myelogenous leukemia (CML-BC) who responded to oral tRA therapy. In vitro marrow studies, including clonogenic assays, immunopheno-typing, cytogenetics and premature chromosome condensation together with chromosome painting provided evidence for the in vivo differentiation and maturation of the malignant cells. The patient achieved a partial remission with reversal of all clinical features of disease, including normalization of peripheral blood counts, complete resolution of fever, fatigue and splenomegaly, and marked maturation of the bone marrow. This response to tRA in CML-BC is unique, and broadens the spectrum of diseases which may respond to retinoids.",
author = "Wiernik, {Peter H.} and Dutcher, {Janice P.} and Paietta, {Elisabeth M.} and Hittelman, {Walter N.} and Rohini Vyas and Margery Strack and Sylvie Castaigne and Laurent Degos and Gallagher, {Robert E.}",
year = "1991",
month = "6",
language = "English (US)",
volume = "5",
pages = "504--509",
journal = "Leukemia",
issn = "0887-6924",
publisher = "Nature Publishing Group",
number = "6",

}

TY - JOUR

T1 - Treatment of promyelocytic blast crisis of chronic myelogenous leukemia with all trans-retinoic acid

AU - Wiernik, Peter H.

AU - Dutcher, Janice P.

AU - Paietta, Elisabeth M.

AU - Hittelman, Walter N.

AU - Vyas, Rohini

AU - Strack, Margery

AU - Castaigne, Sylvie

AU - Degos, Laurent

AU - Gallagher, Robert E.

PY - 1991/6

Y1 - 1991/6

N2 - Two recent reports have described major clinical benefits from all-trans-retinoic acid (tRA) therapy of patients with promyelocytic leukemia (APL). This paper describes the first patient with a blast crisis of chronic myelogenous leukemia (CML-BC) who responded to oral tRA therapy. In vitro marrow studies, including clonogenic assays, immunopheno-typing, cytogenetics and premature chromosome condensation together with chromosome painting provided evidence for the in vivo differentiation and maturation of the malignant cells. The patient achieved a partial remission with reversal of all clinical features of disease, including normalization of peripheral blood counts, complete resolution of fever, fatigue and splenomegaly, and marked maturation of the bone marrow. This response to tRA in CML-BC is unique, and broadens the spectrum of diseases which may respond to retinoids.

AB - Two recent reports have described major clinical benefits from all-trans-retinoic acid (tRA) therapy of patients with promyelocytic leukemia (APL). This paper describes the first patient with a blast crisis of chronic myelogenous leukemia (CML-BC) who responded to oral tRA therapy. In vitro marrow studies, including clonogenic assays, immunopheno-typing, cytogenetics and premature chromosome condensation together with chromosome painting provided evidence for the in vivo differentiation and maturation of the malignant cells. The patient achieved a partial remission with reversal of all clinical features of disease, including normalization of peripheral blood counts, complete resolution of fever, fatigue and splenomegaly, and marked maturation of the bone marrow. This response to tRA in CML-BC is unique, and broadens the spectrum of diseases which may respond to retinoids.

UR - http://www.scopus.com/inward/record.url?scp=0025811182&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025811182&partnerID=8YFLogxK

M3 - Article

C2 - 2056773

AN - SCOPUS:0025811182

VL - 5

SP - 504

EP - 509

JO - Leukemia

JF - Leukemia

SN - 0887-6924

IS - 6

ER -